[1] HU W,LI W,SUM W,et al. Hirsutine ameliorates hepatic and cardiac insulin resistance in high-fat diet-induced diabetic mice and in vitro models[J].Pharmacol Res,2021,177(5):105917.
[2] CALDER?譫N-DUPONTD,TORRE-VILLALVAZO I,D?魱AZ-VILLASE?譙OR A. Is insulin resistance tissue-dependent and substrate-specific? The role of white adipose tissue and skeletal muscle[J]. Biochimie,2023,204(1):48-68.
[3] SANVEE G M ,PANAJATOVIC M V,BOUITBIR J,et al. Mechanisms of insulin resistance by simvastatin in C2C12 myotubes and in mouse skeletal muscle[J]. Biochem Pharmacol,2019,164:23-33.
[4] SONG H,HUANG Q,ZHANG Y,et al. Wheat germ peptide impro-ves glucose metabolism and insulin resistance in HepG2 hepatocytes via regulating SOCS3/IRS1/Akt pathway[J]. Nutr Res,2023, 120:135-144.
[5] UEKI K,KONDO T,KAHN C R,et al. Suppresor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms[J]. Mol Cell Biol,2004,24(12):5434-5446.
[6] LEITNER J M,MAYR F B,FIRBAS C,et al. Reparixin,a specific interleukin-8 inhibitor,has no effects on inflammation during endotoxemia[J]. Int J Immunopathol Pharmacol,2007,20(1):25-36.
[7] SHULMAN G I. Ectopic fat in insulin resistance,dyslipidemia,and cardiometabolic disease[J]. N Engl J Med,2014,371(12):1131.
[8] CHABOWSKI A,ENDZIAN-PIOTROWSKA M,KONSTANTYNO-WICZ K,et al. Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes[J]. Acta Physiol,2013,207(2):346-357.
[9] DAI H B,WANG H Y,WANG F Z,et al. Adrenomedullin ameliorates palmitic acid-induced insulin resistance through PI3K/Akt pathway in adipocytes[J]. Acta Diabetologica,2022,59(5):661-673.
[10] KORBECKI J,BAJDAK-RUSINEK K. The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms[J]. Inflamm Res,2019,68(11):915-932.
[11] DU H,DUAN S,LEI R,et al. Astragalin inhibits insulin resistance and oxidative Stress in palmitic acid-induced HepG2 cells[J]. Curr Top Nutraceut R,2022,20(4):635-640.
[12] SAMUEL V T,SHULMAN G I. The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux[J]. J Clin Invest,2016,126(1):12-22.
[13] BOUCHER J,KLEINRIDDERS A,KAHN C R. Insulin receptor signaling in normal and insulin-resistant states[J].Cold Spring Harb Perspect Biol,2014,6(1):a009191.
[14] WATSON R T,KANZAKI M,PESSIN J E. Regulated membrane trafficking of the insulin-responsive glucose transporter 4 in adipocytes[J].Endocr Rev,2004,25(2):177-204.
[15] RICHTER E A,HARGREAVES M. Exercise,GLUT4,and skeletal muscle glucose uptake[J]. Physiol Rev,2013,93(3):993-1017.
[16] KARNIELI E,ARMONI M. Transcriptional regulation of the insulin-responsive glucose transporter GLUT4 gene: from physiology to pathology[J]. Am J Physiol Endocrinol Metab,2008,295(1):E38-E45.
[17] LETO D,SALTIEL A R. Regulation of glucose transport by insulin: traffic control of GLUT4[J]. Nat Rev Mol Cell Biol,2012,13(6):383-396.
[18] WHITE C A,NICOLA N A. SOCS3: an essential physiological inhibitor of signaling by interleukin-6 and G-CSF family cytokines[J]. JAKSTAT,2013,2(4):e25045.
[19] UEKI K,KONDO T,TSENG YH,et al. Central role of suppressors of cytokine signaling proteins in hepatic steatosis,insulin resistance,and the metabolic syndrome in the mouse[J]. Proc Natl Acad Sci U S A,2004,101(28):10422-10427.
[20] O′CONNOR J C,SHERRY C L,GUEST C B,et al. Type 2 diabetes impairs insulin receptor substrate-2-mediated phosphatidylinositol 3-kinase activity in primary macrophages to induce a state of cytokine resistance to IL-4 in association with overexpression of suppressor of cytokine signaling-3[J].J Immunol,2007,178(11):6886-6893.
[21] WADA T,SUNAGA H,MIYATA K,et al. Aryl hydrocarbon receptor plays protective roles against high fat diet (HFD)-induced hepatic steatosis and the subsequent lipotoxicity via direct transcriptional regulation of socs3 gene expression[J]. J Biol Chem,2016,291(13):7004-7016.